Application of pharmacoeconomics to the use of antibiotics

Clinical Microbiology and Infection

Volumn 6, Issue S3, 2000, Pages 90-92

  Eandi, M ^a   Zara, G Paolo ^a   Pepa, C Della ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE;

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CULTURAL FACTOR; DRUG COST; DRUG HALF LIFE; GROSS NATIONAL PRODUCT; HEALTH CARE SYSTEM; HUMAN; BACTERIAL INFECTION; DECISION MAKING; ECONOMICS; PHARMACOECONOMICS; REVIEW;

BACTERIAL INFECTIONS; CEPHALOSPORINS; DECISION MAKING; DRUG COSTS; ECONOMICS, PHARMACEUTICAL; HUMANS;

EID: 17644436954     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2000.tb02055.x     Document Type: Article

References (15)

1. Weinstein MC, Fineberg HV. Clinical Decision Analysts. Philadelphia, PA: W.B. Saunders, 1980.
2. Thornton JG, Lilford RJ. Decision analysis for medical managers. BMJ 1995; 310: 791-4.
3. Drummond M, Stoddart G, Torrance G. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford Medical Publications. 1987.
4. Bootman L, Townsend R, McGhan W. Principles of Pharmacoeconomics. Cincinnati, OH: Harvey Whitney Books, 1991.
5. Cooke J, Doreau C, Eandi M. Pharmacoeconomic aspecs of antibacterial treatment with cefotaxime. J Chemotherapy 1997; 9(Suppl. 2): 34-45.
6. Eandi M, Zara GP. Economic impact of resistance in the community. Int J Clin Prac Supplement, 1998; 95: 27-38.
7. Gilbert DN, Dworkin RJ, Raber SR, Leggett JE. Outpatient parenteral antimicrobial-drug therapy. NEJM 1997; 337: 829-938.
8. Poretz DM. Outpatient parenteral antibiotic therapy. Int J Antimicrobial Agents 1995; 5: 9-12.
9. Tice AD. Outpatient Parenteral Antibiotic Therapy in different countries. Int J Infect Dis 1996; 1: 102-6.
10. Parker SE, Davey PG. Pharmacocconomics of intravenous drug administration. Pharmacoeconomics 1992; 1: 103-15.
11. Quintilliani R, Cooper BW, Briceland LL, Nightingale CH. Economic impact of streamlining antibiotic administration. Am J Med 1987; 82(Suppl. 4A): 391-4.
12. Eisenberg JM, Kitz DS. Savings from outpatient antibiotic therapy for osteomyelitis: Economic Analysis of a therapeutic strategy. JAMA 1986; 255: 1584-90.
13. Halls GA. The management of infections and antibiotic therapy: a European survey. J Antimicrob Chemother 1993; 31: 985-1000.
14. Grizzard MB, Harris G, Karns H. Use of outpatient parenteral therapy in a Health Maintenance Organization, Rev Inf Dis 1991; 13(Suppl. 2): S174-81.
15. Poretz DM, Eron LJ, Goldenberg RI et al. Intravenous antibiotic therapy in an outpatient setting. JAMA 1982; 248: 336-9.